- page settings
- showhide sidebar
- showhide empty fields
- layout
- (too narrow)
- open all
- close all
- Page Content
- Overview
- External Links
- History
- Referenced
- Tools
- Tree Display
- My WormBase
- My Favorites
- My Library
- Recent Activity
- Comments (0)
history logging is off
Tree Display
My Favorites
My Library
Comments on Rogalski TM et al. (1991) International C. elegans Meeting "GENETIC APPROACHES TO C. ELEGANS RNA POLYMERASE III." (0)
Overview
Rogalski TM, Golomb M, Lancy ED, Riddle DL, Albert PS, & Watson N (1991). GENETIC APPROACHES TO C. ELEGANS RNA POLYMERASE III presented in International C. elegans Meeting. Unpublished information; cite only with author permission.
RNA polymerase III (Rpo m) transcribes genes encoding SS and transfer RNA's. This enzyme and its associated factors have been studied extensively in other systems, but Rpo m function has not been studied genetically in a metazoan. Developmental regulation of Rpo m activity in C. elegans has been suggested by the molecular genetic analysis of nonsense suppressors (Kondo et al., J. Mol. Biol. 215:7-19, 1990). The gene for the largest subunit of Rpo m, rpc-l, has been cloned (Bird and Riddle, Mol. Cell. Biol. 9:4119-4130, 1989) and positioned on the physical map between unc44 and unc-24 on chromosome IV. The availability of cloned genes and an in vitro transcription system (Honda et al., Nucl. Acid Res. 14B:869-881, 1986) provides potential tools for a detailed analysis of Rpo III structure and function using mutants, if appropriate mutants can be identified. Two approaches to genetic analysis of rpc-l have been employed. The first approach utilized resistance to the fungal toxin, ct-amanitin. A unique strain with an extremely amanitin-resistant Rpo II (Rogalski et al., Genetics 126:889-898, 1990) was used as a parent to select even higher levels of resistance. One such mutation was mapped on chromosome IV, and preliminary nuclear run-on assays indicate that Rpo III is abnormally resistant to amanitin, in appropriate recombinants derived from this mutant strain. The mutant Rpo III transcribes SS RNA in the presence of 200 g/ml amanitin, whereas wild-type Rpo m is inhibited by 25 g/ml. These results suggest that the resistance mutation affects Rpo III, and it may be within the rpc-l gene. A second approach to rpc-l genetics utilized a collection of EMSinduced lethal mutations generated by Denise Clark. We mapped fourteen of her lethal mutations to the interval between unc44 and unc-24, a region estimated to contain approximately 30 essential genes. These lethal mutations are now being assigned to complementation groups. Lethal derivatives of the putative amanitin-resistant rpc-l allele will also be sought, and selected lethal strains will be injected with the cloned rpc-l gene in an effort to identify the genetic correlate to rpc-l by DNA transformation. Genetic, phenotypic, and biochemical analysis of these mutants may provide a useful entree into structure- function relationships in this important enzyme.